๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hemodynamic study during transdermal application of nitroglycerin tape in patients with cirrhosis

โœ Scribed by Tadashi Iwao; Atsushi Toyonaga; Michihiro Sumino; Kohsuke Takagi; Kazunori Ohkubo; Rintaroh Inoue; Kyuichi Tanikawa


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
502 KB
Volume
13
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis


We studied 14 patients with portal hypertension and cirrhosis using portal and hepatic vein catheterizations to determine the effects of transdermal application of nitroglycerin tape (containing 10 mg of nitroglycerin and capable of releasing 6 to 7 mg of nitroglycerin in 12 hr) on splanchnic hemodynamics. Patients randomly received nitroglycerin (n = 7) or a placebo (n = 7). No significant changes were observed after the administration of the placebo. In contrast, transdermal nitroglycerin caused a significant reduction in portal pressure, as evaluated by measurements of the portal venous pressure gradient (-22%, p less than 0.01). The reduction of portal pressure was due to a decrease in the portal venous pressure, with no changes in the free hepatic venous pressure. Despite the fall in portal pressure, the hepatic blood flow was maintained. These findings suggest that transdermal nitroglycerin could be potentially useful in the treatment of portal hypertension associated with cirrhosis.


๐Ÿ“œ SIMILAR VOLUMES


Low dose of nitroglycerin failed to impr
โœ Richard Moreau; Dominique Roulot; Alain Braillon; Christophe Gaudin; Antoine Had ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 580 KB

High doses of nitroglycerin may decrease portal pressure in patients with cirrhosis with untoward effects such as arterial hypotension and a decrease in systemic O2 uptake. In the present study, low doses of nitroglycerin (7 to 15 wg per min, i.v.) were administered in 11 patients with cirrhosis in

Improvement in pulmonary hemodynamics du
โœ Michael J. Krowka; Robert P. Frantz; Michael D. McGoon; Cathy Severson; David J. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 125 KB

Pulmonary hypertension associated with increased pulmonary vascular resistance (PVR) and occurring in the setting of portal hypertension is referred to as ''portopulmonary hypertension.'' Intravenous epoprostenol (prostacyclin) is a potent pulmonary and systemic vasodilator with antithrombotic prope